Search results
Guillain-Barre syndrome ‘more common than expected’ with RSV vaccine in older people, CDC reiterates
The Columbian· 7 days agoMore than 10 million older adults have gotten either Pfizer or GSK single-dose shots since early...
California 'overdue' for whooping cough outbreak as cases spike across U.S.
LA Times via Yahoo News· 14 hours agoWhooping cough, a respiratory infection that is particularly deadly for infants, has been relatively...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 3 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Moderna wins second product approval with RSV vaccine
Market Watch· 6 days agoThe Food and Drug Administration approved the mRNA shot, mResvia, for adults 60 and older,...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 3 days agoWe got a taste of this during the past season...The biotech received regulatory approval for its respiratory syncytial virus (RSV) vaccine, paving the...
